SHANG.FOS.PHARM.GR.H YC 1 financial statements, including revenue, expenses, profit, and loss
The total revenue of 08HH for the last semiannual is 2.50 B EUR, and it's 11.41% lower compared to the previous semiannual. The net income of H2 23 is 77.06 M EUR.